COVID-19

Rheumatic Disease Patients Still Need Pandemic Treatment Counsel

November 05, 2020

A survey of 9,004 patients with rheumatic disease―both autoimmune-related and non-autoimmune―shows that patients may need continued medication counseling through the duration of the pandemic, finds a study due to be presented on Friday at the American College of Rheumatology.

COVID Deaths Are High Among Waitlisted Kidney Transplant Patients

October 29, 2020

Although mortality rates for kidney transplant recipients with COVID-19 are known to be high, end stage kidney disease patients with COVID-19 appear to have a higher risk of mortality than patients with new kidneys.

Research Update: Cytokine Storm Syndrome

September 28, 2020

Various drug therapies, including several cytokine blockers, are showing promise in addressing COVID-19 related cytokine storm syndrome, says Dr. Randall Cron of Children’s Hospital of Alabama.

COVID-19 Rheumatic Disease News Roundup

September 01, 2020

Rheumatic disease patients have a unique set of concerns when it comes to COVID-19. To date, the evidence suggests, that for patients who have few, if any comorbidities, an infection may not be any worse than those in the general population. Learn more in this news roundup and slideshow.

Study Hints at COVID-19 Risk for Rheumatic Disease Patients

August 27, 2020

Researchers in China write in the current issue of The Lancet Rheumatology that patients with autoimmune rheumatic disease might be more susceptible to COVID-19 infections than the general population.

These Two Tests May Determine COVID-19 Severity

August 27, 2020

A proportion of patients with COVID-19 are more prone to developing COVID-19-associated hyperinflammation regardless of age and comorbidity status, finds an observational study published on Friday in The Lancet Rheumatology.

Long-Term Use of Hydroxychloroquine May Increase Mortality Risk

August 25, 2020

A retrospective study published in The Lancet Rheumatology shows that the long-term use of hydroxychloroquine to treat rheumatoid arthritis patients may increase the risk of cardiovascular mortality.

Podcast: Making Sense of the COVID-19 Infodemic

August 13, 2020

Since the start of the COVID-19 pandemic early this year, there have been a number of studies published to test the effectiveness of hydroxychloroquine as a possible treatment. In today’s edition of Overdrive, the podcast from Rheumatology Network, Dr. Daniel Solomon, editor-in-chief of Arthritis and Rheumatology, helps us make sense of the science.

The COVID-19 Infodemic Simplified

August 07, 2020

In this week's news roundup and one-on-one interview, we talk with Dr. Daniel Solomon of Brigham and Women’s Hospital and editor-in-chief of the journal Arthritis and Rheumatology. Dr. Solomon and colleagues recently published a commentary called “The Infodemic of COVID-19” in which they break down the inundation of new science on hydroxychloroquine and the cytokine storm.

First COVID-19, then Kawasaki-like Disease in Children

July 24, 2020

Children with COVID-19 can develop pediatric, inflammatory multisystemic syndrome, or PIMS, which can lead to symptoms similar to that of a painful vasculitis condition called Kawasaki disease. Today we talk with Jagadeesh Bayry, Ph.D., and Caroline Galeotti, M.D., of the University of Paris who recently described in Nature Reviews Rheumatology related pediatric cases they saw in their clinic.